Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial

2024 . Karaa, Amel | Bertini, Enrico | Carelli, Valerio | Cohen, Bruce | Ennes, Gregory M. | Falk, Marni J. | Goldstein, Amy | Gorman, Gráinne | Haas, Richard | Hirano, Michio | Klopstock, Thomas | Koenig, Mary Kay | Kornblum, Cornelia | Lamperti, Costanza | Lehman, Anna | Longo, Nicola | Molnar, Maria Judit | Parikh, Sumit | Phan, Han | Pitceathly, Robert D. S. | Saneto, Russekk | Scaglia, Fernando | Servidei, Serenella | Tarnopolsky, Mark | Toscano, Antonio | Van Hove, Johan L. K. | Vissing, John | Vockley, Jerry | Finman, Jeffrey S. | Abbruscato, Anthony | Brown, David A. | Sullivan, Alana | Shiffer, James A. | Mancuso, Michelango | on behalf of the MMPOWER-3 Trial Investigators